Tagged with Medigen Vaccine Biologics

MVC’s WHO-Partnered Vaccine a First for Taiwan

Taiwan MVC’s WHO-Partnered Vaccine a First for Taiwan

Taiwan As a part of the World Health Organisation’s (WHO) COVID-19 Technology Access Pool (C-TAP), the Medicines Patent Pool has signed a worldwide license with Medigen Vaccine Biologics (MVC) for its COVID-19 vaccine, representing a debut on two fronts. Not only is this the first time a COVID-19 vaccine developed by…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here